Monroe Capital [MRCC] vs Brookfield [BN] Detailed Stock Comparison

Monroe Capital
NASDAQ
Loading...

Brookfield
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Monroe Capital wins in 11 metrics, Brookfield wins in 6 metrics, with 0 ties. Monroe Capital appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Monroe Capital | Brookfield | Better |
---|---|---|---|
P/E Ratio (TTM) | 83.00 | 232.59 | Monroe Capital |
Price-to-Book Ratio | 0.90 | 2.46 | Monroe Capital |
Debt-to-Equity Ratio | 116.14 | 156.81 | Monroe Capital |
PEG Ratio | -0.52 | 11.49 | Monroe Capital |
EV/EBITDA | N/A | 14.75 | N/A |
Profit Margin (TTM) | 3.74% | 0.73% | Monroe Capital |
Operating Margin (TTM) | 72.81% | 27.05% | Monroe Capital |
EBITDA Margin (TTM) | 72.81% | 27.05% | Monroe Capital |
Return on Equity | 1.01% | 0.95% | Monroe Capital |
Return on Assets (TTM) | 5.45% | 2.69% | Monroe Capital |
Free Cash Flow (TTM) | $35.96M | $-3.60B | Monroe Capital |
Dividend Yield | 15.72% | N/A | N/A |
1-Year Return | -4.42% | 44.29% | Brookfield |
Price-to-Sales Ratio (TTM) | 3.16 | 1.24 | Brookfield |
Enterprise Value | $368.00M | $455.84B | Brookfield |
EV/Revenue Ratio | 7.18 | 5.45 | Brookfield |
Gross Profit Margin (TTM) | N/A | 38.73% | N/A |
Revenue per Share (TTM) | $2 | $55 | Brookfield |
Earnings per Share (Diluted) | $0.09 | $0.29 | Brookfield |
Beta (Stock Volatility) | 0.97 | 2.19 | Monroe Capital |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Monroe Capital vs Brookfield Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Monroe Capital | -0.26% | 1.75% | 21.94% | 19.62% | -7.13% | -12.40% |
Brookfield | 1.87% | 1.20% | -0.09% | 14.96% | 24.23% | 15.66% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Monroe Capital | -4.42% | -11.27% | 0.00% | -48.75% | -50.07% | -50.07% |
Brookfield | 44.29% | 63.70% | 149.38% | 306.85% | 705.81% | 1,084.34% |
Performance & Financial Health Analysis: Monroe Capital vs Brookfield
Metric | MRCC | BN |
---|---|---|
Market Information | ||
Market Cap | $184.60M | $103.45B |
Market Cap Category | Micro cap | Large cap |
10 Day Avg. Volume | 73,270 | 2,772,840 |
90 Day Avg. Volume | 119,557 | 2,169,097 |
Last Close | $7.56 | $66.56 |
52 Week Range | $5.96 - $8.85 | $43.61 - $68.75 |
% from 52W High | -14.58% | -3.19% |
All-Time High | $16.37 (Sep 05, 2016) | $68.75 (Jul 18, 2025) |
% from All-Time High | -53.82% | -3.19% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.37% | -0.22% |
Quarterly Earnings Growth | -1.13% | -0.28% |
Financial Health | ||
Profit Margin (TTM) | 0.04% | 0.01% |
Operating Margin (TTM) | 0.73% | 0.27% |
Return on Equity (TTM) | 0.01% | 0.01% |
Debt to Equity (MRQ) | 116.14 | 156.81 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $8.29 | $27.44 |
Cash per Share (MRQ) | $0.11 | $8.32 |
Operating Cash Flow (TTM) | $118.27M | $8.95B |
Levered Free Cash Flow (TTM) | $11.17M | $-2,725,499,904 |
Dividends | ||
Last 12-Month Dividend Yield | 15.72% | N/A |
Last 12-Month Dividend | $1.00 | N/A |
Valuation & Enterprise Metrics Analysis: Monroe Capital vs Brookfield
Metric | MRCC | BN |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 83.00 | 232.59 |
Forward P/E | 7.40 | 11.49 |
PEG Ratio | -0.52 | 11.49 |
Price to Sales (TTM) | 3.16 | 1.24 |
Price to Book (MRQ) | 0.90 | 2.46 |
Market Capitalization | ||
Market Capitalization | $184.60M | $103.45B |
Enterprise Value | $368.00M | $455.84B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 7.18 | 5.45 |
Enterprise to EBITDA | N/A | 14.75 |
Risk & Other Metrics | ||
Beta | 0.97 | 2.19 |
Book Value per Share (MRQ) | $8.29 | $27.44 |
Financial Statements Comparison: Monroe Capital vs Brookfield
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | MRCC | BN |
---|---|---|
Revenue/Sales | $-568,000 | $17.94B |
Cost of Goods Sold | N/A | $11.00B |
Gross Profit | N/A | $6.95B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | N/A | $4.48B |
EBITDA | N/A | $8.23B |
Pre-Tax Income | $-1.91M | $598.00M |
Income Tax | $-43,000 | $383.00M |
Net Income (Profit) | $-1.87M | $215.00M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | MRCC | BN |
---|---|---|
Cash & Equivalents | $6.46M | $12.44B |
Total Current Assets | N/A | $65.21B |
Total Current Liabilities | N/A | $58.80B |
Long-Term Debt | $269.09M | $245.86B |
Total Shareholders Equity | $186.88M | $158.93B |
Retained Earnings | $-110.86M | N/A |
Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | MRCC | BN |
---|---|---|
Operating Cash Flow | $-1.67M | $3.48B |
Capital Expenditures | N/A | $-1.83B |
Free Cash Flow | $26.07M | $4.00M |
Debt Repayment | $-49.10M | $-20.53B |
Common Stock Repurchase | N/A | $-136.00M |
Short Interest & Institutional Ownership Analysis
Metric | MRCC | BN |
---|---|---|
Shares Short | 98,698 | 15.19M |
Short Ratio | 0.75 | 8.18 |
Short % of Float | 0.00% | N/A |
Average Daily Volume (10 Day) | 73,270 | 2,772,840 |
Average Daily Volume (90 Day) | 119,557 | 2,169,097 |
Shares Outstanding | 21.67M | 1.51B |
Float Shares | N/A | 1.17B |
% Held by Insiders | 0.01% | 0.18% |
% Held by Institutions | 0.17% | 0.58% |
Dividend Analysis & Yield Comparison: Monroe Capital vs Brookfield
Metric | MRCC | BN |
---|---|---|
Last 12-Month Dividend | $1.00 | N/A |
Last 12-Month Dividend Yield | 15.72% | N/A |
3-Year Avg Annual Dividend | $1.00 | N/A |
3-Year Avg Dividend Yield | 3.30% | N/A |
3-Year Total Dividends | $3.00 | N/A |
Ex-Dividend Date | Jun 16, 2025 | N/A |